ALIMENTARY PHARMACOLOGY & THERAPEUTICS, vol.21, no.9, pp.1163-1171, 2005 (SCI-Expanded)
Background: Treatment with interferon-alpha has been shown to be effective in one-third of hepatitis B e antigen-positive chronic hepatitis B patients, but is clinically associated with relevant adverse events.